Brucellosis is a worldwide zoonosis affecting animal and human health. In the last several
decades, much research has been performed to develop safer Brucella vaccines to control …

There is currently no licensed vaccine for brucellosis in humans. Available animal vaccines
may cause disease and are considered unsuitable for use in humans. However, the …

Available vaccines against Brucella spp. are live attenuated Brucella strains. In order to
engineer a better vaccine to be used in animals and humans, our laboratory aims to develop …

As Brucella infections occur mainly through mucosal surfaces, the development of mucosal
administered vaccines could be radical for the control of brucellosis. In this work we …

Abstract Development and implementation of health management plans is the cornerstone
of profitable farms; prevention of microbial diseases by means of vaccination is an integral …

The immunogenicity and protective efficacy of recombinant SurA (rSurA) and rDnaK from
Brucella spp. were evaluated in BALB/c mice. Immunization with rSurA in adjuvant induced …

The field of vaccine development has seen an increase in the number of rationally designed
technologies that increase effectiveness against vaccine-resistant pathogens, while not …

Brucella is a facultatively intracellular bacterial pathogen and the cause of worldwide
zoonotic infections, infamous for its ability to evade the immune system and persist …